CMV Reactivation Pre and Post Letermovir Prophylaxis, a Single Centre Review of Clinical Outcomes and Resource Utilization

• Published in: Blood Vol. 144; no. Supplement 1; p. 7649
• Main Authors: Cherniawsky, Hannah, Chung, Shanee, Lacaria, Katie, Lau, Jessica, Forrest, Donna L., Roy, Claudie, Stubbins, Ryan J, Rodrigo, Judith Anula, White, Jennifer, Abou Mourad, Yasser, Sanford, David, Song, Kevin, Nantel, Stephen H., Kuchenbauer, Florian, Lad, Deepesh, Toze, Cynthia L., Narayanan, Sujaatha, Nevill, Thomas J., Cao, Lillian, Mountford, Carmen, Wright, Alissa, Ladak, Aamir
• Format: Journal Article
• Language: English
• Published: Elsevier Inc 05.11.2024

Introduction Prospective, randomized trials have demonstrated reduction in the incidence of clinically significant CMV infections (csCMVi) with use of letermovir prophylaxis (LP) in allogeneic hematopoietic stem cell transplant (alloHSCT). Publicly funded LP became available at our cent for routine...